Telix Pharmaceuticals Cash Flow Statement

TLX A$3.83 -0.1 -2.5%

26/02/21

Adventurous, Mid Cap, Momentum Trap

Market Cap £545.8m

Enterprise Value £533.9m

Revenue £1.84m

Quality

Value

Momentum

StockRank™

To unlock Telix Pharmaceuticals's cashflow statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M
Currency:	AUD	AUD	AUD


Changes in Working Capital
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.